BSE · 524748
Link Pharma Chem Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹28 Cr with net profit ₹0 Cr — a 0.28% net margin, versus -4.01% the period before.
Shareholding
As of 2026-06-30
- Promoter52.4%
- Public47.58%
- DII0.02%
6,005 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Chemicals · ranked #136 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 286.45 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,606 Cr | 298.74 | 26.05 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,369 Cr | 134.68 | 5.58 | 13.07% | 13.01% |
| Linde India Limited | ₹57,332 Cr | 104.57 | 13.44 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹50,334 Cr | 461.91 | 6.45 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,559 Cr | 98.05 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,965 Cr | 183.04 | 9.8 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,845 Cr | 193.44 | 8.25 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,840 Cr | 103.95 | 3.91 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,530 Cr | 147.31 | 3 | 10.77% | 6.41% |
| Link Pharma Chem Ltd.(this company) | ₹12 Cr | 152.65 | 0.85 | 0.6% | 0.29% |
AI analysis
AI-generated · google/gemini-2.5-flashLink Pharma Chem Ltd. (524748) has a market capitalization of Rs 12 Cr and a current PE ratio of 158.29. The company's book value per share is Rs 28.81, with an EPS of Rs 0.17. It has a high 52-week price of Rs 41.9 and a low of Rs 21.
Positives
- +Promoter shareholding is over 50% at 52.4018% as of June 30, 2026.
- +The Return on Equity (ROE) is 60.13%.
- +No shares have been pledged by the promoters, with promoter pledge at 0%.
Negatives
- −The company reported a net loss of Rs -1.0273 Cr in Mar 2025 and Rs -1.3629 Cr in Mar 2024.
- −Annual revenue has declined from Rs 54.025 Cr in Mar 2022 to Rs 25.6199 Cr in Mar 2025.
- −The company has been under Graded Surveillance Measure (GSM) Stage 0.
- −The Return on Capital Employed (ROCE) is low at 3.3091%.
- −Quarterly net profit was negative for Dec 2024 (Rs -0.67 Cr), Mar 2025 (Rs -0.35 Cr), and Mar 2026 (Rs -0.41 Cr).
Financial Performance
Link Pharma Chem Ltd. reported annual revenue of Rs 25.6199 Cr in Mar 2025, a decrease from Rs 30.538 Cr in Mar 2024. Net profit also declined, showing a loss of Rs -1.0273 Cr in Mar 2025 compared to a loss of Rs -1.3629 Cr in Mar 2024. Earnings per share (EPS) were Rs -2.31 in Mar 2025, following Rs -3.07 in Mar 2024. The latest quarterly revenue in Mar 2026 was Rs 6.59 Cr, with a net profit of Rs -0.41 Cr.
Profitability & Returns
The company's profit margin stood at 29.18%. Return on Capital Employed (ROCE) was 3.3091%, while Return on Equity (ROE) was 60.13%. However, the company has reported negative EBITDA for recent annual periods, including Rs -0.6271 Cr in Mar 2025 and Rs -1.0438 Cr in Mar 2024. Quarterly EBITDA in Mar 2026 was Rs -0.34 Cr.
Balance Sheet
Link Pharma Chem Ltd. has a debt-to-equity ratio of 0.57. There is no dividend yield reported for the company. The book value per share is Rs 28.81. The company has experienced declining net profits and revenues in recent annual periods.
Ownership & Pledges
As of June 30, 2026, promoters held 52.4018% of the shares, while the public held 47.5824%. DIIs held 0.0158%. The promoter holding has not been pledged. The number of shareholders was 6005 as of June 30, 2026.
Regulatory & Surveillance
Link Pharma Chem Ltd. is under GSM (Graded Surveillance Measure) Stage 0. This indicates that the stock is under regulatory scrutiny due to certain parameters. The company has one surveillance measure, GSM, currently active.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.